NEW YORK (GenomeWeb News) – Ariadne and Quertle today announced a partnership to use Ariadne's technology to enhance search results from Quertle's search engine for biomedical literature.
Ariadne will also provide technical resources to the partnership. Financial terms were not disclosed.
Quertle is a search engine that uses semantic-driven text analytics "to find conceptual relationships scattered throughout a document," the companies said in a joint statement. In addition to using query terms, Quertle's Power Terms technology identifies key concepts and provides the "most relevant literature" in search results.
Under the collaboration, components of Ariadne's MedScan technology, comprised of a set of patent-pending algorithms, will be used to enhance the search engine to enable "highly quality information and data retrieval" from publicly available information, text, journals, and datasets, the two companies said. The extracted data is then translated into biological relationships "which supports a wide range of biological applications," such as Ariadne's Pathway Studio software.
Ariadne will also package Quertle's semantic search engine as an appliance solution to the pharmaceutical and agricultural industry.